
Knock Out Mouse Model
Description
Global Knock Out Mouse Model Market to Reach US$1.7 Billion by 2030
The global market for Knock Out Mouse Model estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Constitutive Knockout Mouse, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$886.8 Million by the end of the analysis period. Growth in the Conditional Knockout Mouse segment is estimated at 4.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$361.8 Million While China is Forecast to Grow at 7.3% CAGR
The Knock Out Mouse Model market in the U.S. is estimated at US$361.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$341.1 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.
Global Knock Out Mouse Model Market - Key Trends & Drivers Summarized
Why Are Knock Out Mouse Models Considered Indispensable Tools in Biomedical Research?
Knock out (KO) mouse models have become indispensable assets in translational and fundamental biomedical research due to their ability to elucidate gene function by completely inactivating specific genes. These models offer researchers a powerful platform to study the physiological consequences of gene deletion, providing insight into disease mechanisms, drug targets, and therapeutic pathways. Since the introduction of gene targeting techniques via homologous recombination in embryonic stem cells, KO mouse models have evolved into essential tools for modeling monogenic diseases, cancer, immunological disorders, and metabolic syndromes. Their genetic manipulability and physiological resemblance to humans make them especially valuable in preclinical validation and toxicological studies.
Recent advancements have led to the development of sophisticated conditional and inducible KO models, wherein gene silencing can be restricted to specific tissues or timeframes. This granularity is vital for dissecting gene functions that may be lethal if knocked out systemically. Such refinements have expanded the applicability of KO mice beyond early developmental studies into aging, regenerative biology, and chronic disease modeling. Additionally, innovations in high-throughput gene editing and sequencing are enabling the generation of large-scale KO mouse libraries, further accelerating genotype-to-phenotype correlations. The availability of global initiatives like the International Knockout Mouse Consortium (IKMC) and the Knockout Mouse Project (KOMP) is helping centralize resources and democratize access, thus scaling research across academia and biotech sectors.
How Are CRISPR and High-Throughput Engineering Reshaping Model Development?
The advent of CRISPR/Cas9 technology has significantly lowered the time and cost required to generate KO mouse models, thereby democratizing their use across smaller labs and commercial CROs. Traditional homologous recombination techniques, which could take up to a year to develop a stable KO line, have now been supplemented or replaced by CRISPR-based systems that enable precise, site-specific gene disruption in a fraction of the time. Multiplex gene editing-targeting multiple genes simultaneously-is increasingly being used to model complex, polygenic diseases such as diabetes, Alzheimer’s, and autoimmune conditions, offering new avenues for precision medicine research.
High-throughput pipelines and automation technologies are also transforming KO mouse production. Facilities equipped with robotic microinjection systems, automated embryo transfer, and digital phenotyping platforms are shortening lead times and increasing model reproducibility. Furthermore, the integration of artificial intelligence into phenotypic screening is allowing for faster identification of observable traits, thereby enhancing throughput in both discovery and validation phases. CROs and contract breeding companies are increasingly offering off-the-shelf and custom KO models, often bundled with phenotypic validation, housing, and tissue collection services, which are streamlining R&D workflows for pharmaceutical companies and academic researchers alike.
The demand for conditional and tissue-specific KO models is growing in tandem with advancements in promoter design and inducible recombination systems, such as Cre-loxP and FLP/FRT. These models are instrumental in overcoming embryonic lethality and studying gene function in postnatal physiology or adult disease states. Additionally, dual recombinase systems are gaining traction for their ability to study gene-gene interactions and pathway cross-talk in a controlled environment, further enriching the functional genomics toolbox.
Which Research Domains and Institutional Trends Are Driving Model Utilization?
The utilization of KO mouse models is seeing rapid growth across oncology, neurology, immunology, and metabolic research domains. In cancer biology, KO mice are used extensively to validate tumor suppressor genes, study oncogene function, and model resistance mechanisms to targeted therapies. Researchers are creating isogenic KO mouse strains with humanized immune systems to evaluate tumor-immune interactions and the efficacy of immuno-oncology candidates. In neuroscience, KO models are being leveraged to study gene involvement in neurodevelopmental and neurodegenerative disorders such as autism, Parkinson’s disease, and epilepsy, particularly through region-specific gene inactivation.
Academic institutions, government-funded initiatives, and pharmaceutical companies are all scaling investments in KO model infrastructure. Centralized mouse repositories and breeding facilities are helping standardize protocols and ensure reproducibility. Meanwhile, the increasing emphasis on open science and data sharing is leading to public repositories of KO strain phenotypic data, facilitating cross-laboratory collaboration. Initiatives like the European Mouse Mutant Archive (EMMA) and the Mouse Genome Informatics (MGI) platform provide searchable databases for researchers worldwide, allowing access to annotated KO lines, phenotypic data, and breeding protocols.
Another key trend is the growing reliance on KO models in drug repositioning and toxicogenomics. By knocking out drug target genes in preclinical models, researchers can determine potential off-target effects, elucidate compensatory pathways, and improve early attrition rates. Regulatory bodies, too, are recognizing the value of KO models in toxicology packages and are encouraging their use in safety pharmacology and biomarker validation. Increasing demand from regulatory science, coupled with the growing availability of tailored KO services, is significantly expanding the commercial opportunity for service providers in this space.
What Is Fueling the Growth Trajectory of the Knock Out Mouse Model Market?
The growth in the global knock out mouse model market is driven by several factors, including the accelerated adoption of CRISPR gene editing, rising research activity in precision medicine, and growing demand for humanized and tissue-specific animal models. The expanding prevalence of chronic and rare diseases has intensified the search for functional genomics tools that offer mechanistic insights into gene-disease relationships. KO mouse models are playing a central role in this effort by serving as in vivo validation platforms for novel targets and biomarkers, particularly in oncology and neurological research pipelines.
Technological advances in embryo manipulation, stem cell culturing, and in vivo imaging are enabling faster model generation and longitudinal monitoring, which are improving the efficiency and relevance of preclinical trials. Commercial CROs and transgenic service providers are scaling operations to cater to growing client demand, particularly in Asia-Pacific and North America. Moreover, as pharmaceutical firms adopt target deconvolution and pathway elucidation strategies earlier in the discovery phase, KO models are being positioned as essential inputs in the design of first-in-class molecules. The global rise in biologics and gene therapies is further reinforcing the demand for precise animal models that replicate human gene expression environments.
Government funding and public-private partnerships continue to play a vital role in sustaining the KO model ecosystem. National biobanks, model organism consortia, and translational research centers are driving KO adoption by integrating them into multi-omics pipelines that combine genomics, transcriptomics, and metabolomics. As ethical concerns and animal welfare regulations become more stringent, there is also a shift toward reducing, refining, and replacing animal use-leading to smarter study designs where KO models are used more judiciously and efficiently. Together, these scientific, commercial, and regulatory forces are underpinning sustained growth and innovation in the knock out mouse model market.
SCOPE OF STUDY:The report analyzes the Knock Out Mouse Model market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Constitutive Knockout Mouse, Conditional Knockout Mouse, Protein Function Knockout Mouse); Application (Oncology Application, Neurology Application, Cardiovascular Application, Other Applications); End-User (Clinical Research Organizations End-User, Pharma & Biotechnology Companies End-User, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 32 Featured) -
- Biocytogen
- Charles River Laboratories
- Cyagen Biosciences
- genOway
- GemPharmatech
- Harbour BioMed
- Horizon Discovery (Revvity)
- Ingenious Targeting Laboratory
- Inotiv
- JAX (The Jackson Laboratory)
- KOMP Repository (MMRRC UC Davis)
- Merck KGaA
- Nanjing Galaxy Biopharma
- Ozgene
- PolyGene
- Shanghai Model Organisms Center
- Taconic Biosciences
- TransCure bioServices
- Transgenic Inc.
- Yecuris Corporation
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Knock Out Mouse Model – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growing Use of Knockout Mice in Functional Genomics Expands Preclinical Research Opportunities
- Increased Emphasis on Humanized Mouse Models Throws the Spotlight on Precision Gene Editing
- CRISPR/Cas9 Technology Adoption Propels Efficiency in Targeted Gene Knockout Studies
- Expansion of Rare Disease Research Spurs Growth in Conditional Knockout Mouse Demand
- Integration of AI in Phenotyping Platforms Strengthens Interpretation of Complex Traits
- Rising Demand for Immuno-Oncology Studies Drives Use of Transgenic Mouse Models
- Global Shift Toward Personalized Medicine Expands Role of Mouse Models in Drug Development
- Surge in Academic-Industry Collaborations Fuels Investments in Custom Model Development
- Standardization Initiatives in Animal Model Repositories Enhance Reproducibility in Research
- Growth in In Vivo Validation of RNA Therapies Spurs Demand for RNA-Targeted Knockouts
- Ethical and Regulatory Constraints Throw the Spotlight on Alternatives and Refinement Protocols
- Increased Funding in Rare Genetic Disorder Research Propels Use of Gene-Edited Rodents
- Advancements in Germline Transmission Techniques Improve Model Generation Timelines
- High Failure Rates in Clinical Translation Drive Adoption of Predictive Mouse Models
- Global Expansion of Biotech Startups Strengthens Demand for Specialized Animal Models
- Commercialization of Off-the-Shelf Knockout Models Accelerates Time-to-Experiment
- Use of Mouse Embryonic Stem Cells for Gene Targeting Expands Model Generation Capabilities
- Rising Demand for Dual and Triple Knockout Combinations Spurs Platform Innovation
- Challenges in Breeding Efficiency and Colony Maintenance Add Operational Complexity
- Integration of Bioinformatics in Study Design Enhances Genotype-to-Phenotype Linkage
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Knock Out Mouse Model Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Knock Out Mouse Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Knock Out Mouse Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Knock Out Mouse Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Constitutive Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Constitutive Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Constitutive Knockout Mouse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Conditional Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Conditional Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Conditional Knockout Mouse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Protein Function Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Protein Function Knockout Mouse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Protein Function Knockout Mouse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Clinical Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Clinical Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Clinical Research Organizations End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotechnology Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Pharma & Biotechnology Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Pharma & Biotechnology Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 35: USA Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: USA 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: USA 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- CANADA
- TABLE 44: Canada Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: Canada 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- JAPAN
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 53: Japan Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: Japan 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- CHINA
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 62: China Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: China Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: China 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: China 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- EUROPE
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 71: Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Knock Out Mouse Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Knock Out Mouse Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- FRANCE
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 83: France Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: France Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: France 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: France 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- GERMANY
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 92: Germany Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: Germany 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- ITALY
- TABLE 101: Italy Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: Italy 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- UNITED KINGDOM
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 110: UK Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: UK 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: UK 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- SPAIN
- TABLE 119: Spain Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: Spain 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 122: Spain Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: Spain 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- RUSSIA
- TABLE 128: Russia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Russia 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 131: Russia Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: Russia 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- REST OF EUROPE
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: Rest of Europe 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: Rest of Europe 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- ASIA-PACIFIC
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Knock Out Mouse Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- AUSTRALIA
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 158: Australia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Australia 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 161: Australia Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Australia 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- INDIA
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 167: India Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: India Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: India 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 170: India Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: India 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- SOUTH KOREA
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: South Korea 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: South Korea 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- LATIN AMERICA
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Knock Out Mouse Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: Latin America 16-Year Perspective for Knock Out Mouse Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: Latin America 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- ARGENTINA
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Argentina 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Argentina 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- BRAZIL
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 217: Brazil 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 220: Brazil 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- MEXICO
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 226: Mexico 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 229: Mexico 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 235: Rest of Latin America 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- MIDDLE EAST
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Knock Out Mouse Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 244: Middle East 16-Year Perspective for Knock Out Mouse Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 247: Middle East 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- IRAN
- TABLE 254: Iran Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 256: Iran 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 257: Iran Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 259: Iran 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- ISRAEL
- TABLE 263: Israel Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 265: Israel 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 266: Israel Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 268: Israel 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- SAUDI ARABIA
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 274: Saudi Arabia 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 281: UAE Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 283: UAE 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 284: UAE Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 286: UAE 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 292: Rest of Middle East 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- AFRICA
- Knock Out Mouse Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 299: Africa Recent Past, Current & Future Analysis for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Knock Out Mouse Model by Type - Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 301: Africa 16-Year Perspective for Knock Out Mouse Model by Type - Percentage Breakdown of Value Sales for Constitutive Knockout Mouse, Conditional Knockout Mouse and Protein Function Knockout Mouse for the Years 2014, 2025 & 2030
- TABLE 302: Africa Recent Past, Current & Future Analysis for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Knock Out Mouse Model by End-user - Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 304: Africa 16-Year Perspective for Knock Out Mouse Model by End-user - Percentage Breakdown of Value Sales for Other End-Users, Clinical Research Organizations End-User and Pharma & Biotechnology Companies End-User for the Years 2014, 2025 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Knock Out Mouse Model by Application - Oncology Application, Neurology Application, Cardiovascular Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Knock Out Mouse Model by Application - Percentage Breakdown of Value Sales for Oncology Application, Neurology Application, Cardiovascular Application and Other Applications for the Years 2014, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates